218 related articles for article (PubMed ID: 2650409)
21. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
Hahn T; McCarthy PL; Zhang MJ; Wang D; Arora M; Frangoul H; Gale RP; Hale GA; Horan J; Isola L; Maziarz RT; van Rood JJ; Gupta V; Halter J; Reddy V; Tiberghien P; Litzow M; Anasetti C; Pavletic S; Ringdén O
J Clin Oncol; 2008 Dec; 26(35):5728-34. PubMed ID: 18981462
[TBL] [Abstract][Full Text] [Related]
22. Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation.
Kolb HJ; Bender-Götze C; Holler E; Mittermüller J; Grosse-Wilde H; Wank R; Eckstein R; Scholz S; Haas RJ; Mempel W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):421-5. PubMed ID: 2480284
[TBL] [Abstract][Full Text] [Related]
23. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic bone marrow transplantation using unrelated marrow donors.
Fay JW; Collins RH; Piñeiro L
Bone Marrow Transplant; 1993; 11 Suppl 1():81-2. PubMed ID: 8448557
[No Abstract] [Full Text] [Related]
25. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
Gratwohl A; Hermans J; Niederwieser D; Frassoni F; Arcese W; Gahrton G; Bandini G; Carreras E; Vernant JP; Bosi A
Bone Marrow Transplant; 1993 Nov; 12(5):509-16. PubMed ID: 8298562
[TBL] [Abstract][Full Text] [Related]
26. Individual physician practice variation in hematopoietic cell transplantation.
Lee SJ; Joffe S; Artz AS; Champlin RE; Davies SM; Jagasia M; Kernan NA; Loberiza FR; Soiffer RJ; Eapen M
J Clin Oncol; 2008 May; 26(13):2162-70. PubMed ID: 18378566
[TBL] [Abstract][Full Text] [Related]
27. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks.
Igaki H; Karasawa K; Sakamaki H; Saito H; Nakagawa K; Ohtomo K; Tanaka Y
Strahlenther Onkol; 2005 Nov; 181(11):704-8. PubMed ID: 16254705
[TBL] [Abstract][Full Text] [Related]
28. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS
Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.
Apperley JF; Jones L; Hale G; Waldmann H; Hows J; Rombos Y; Tsatalas C; Marcus RE; Goolden AW; Gordon-Smith EC
Bone Marrow Transplant; 1986 May; 1(1):53-66. PubMed ID: 3332120
[TBL] [Abstract][Full Text] [Related]
30. Mother as HLA haploidentical marrow donor for children with advanced leukemia.
Polchi P; Galimberti M; Lucarelli G; Durazzi SM; Angelucci E; Baronciani D; Donati M
Bone Marrow Transplant; 1991; 7 Suppl 2():124. PubMed ID: 1878671
[No Abstract] [Full Text] [Related]
31. [The role of bone marrow transplantation in the treatment of leukemia].
Robak T
Przegl Lek; 1990; 47(10):723-7. PubMed ID: 2089452
[No Abstract] [Full Text] [Related]
32. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow.
Garderet L; Labopin M; Gorin NC; Polge E; Fouillard L; Ehninger GE; Ringden O; Finke J; Tura S; Frassoni F
Bone Marrow Transplant; 2003 Jan; 31(1):23-9. PubMed ID: 12621503
[TBL] [Abstract][Full Text] [Related]
33. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
34. Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.
Champlin R; Giralt S; Przepiorka D; Ho W; Lee K; Gajewski J; Nimer S; Andersson B; Wallerstein R; Ippolito C
Prog Clin Biol Res; 1992; 377():385-94; discussion 395-8. PubMed ID: 1438435
[No Abstract] [Full Text] [Related]
35. [Allogenic bone marrow transplantation in acute leukemias and chronic myeloid leukemia].
Mendeleeva LP
Ter Arkh; 2003; 75(7):89-94. PubMed ID: 12934492
[No Abstract] [Full Text] [Related]
36. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow transplantation in childhood leukaemia--experience and strategies in the Federal Republic of Germany.
Niethammer D; Dopfer R; Ehninger G; Schäfer UW; Stollmann B; Rister M; Schmitz N; Bender-Götze C; Haas RJ; Kolb H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):361-6. PubMed ID: 2480275
[TBL] [Abstract][Full Text] [Related]
38. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
39. The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia.
Frassoni F; Bacigalupo A; Sessarego M; Gualandi F; Lamparelli T; Van Lint MT; Occhini D; Corvò R; Scarpati D; Vitale V
Bone Marrow Transplant; 1991; 7 Suppl 2():130. PubMed ID: 1878675
[No Abstract] [Full Text] [Related]
40. Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
Buckner CD; Clift RA; Appelbaum FR; Storb R; Petersen FB; Sanders JE; Thomas ED; Hansen JA
Bone Marrow Transplant; 1991; 7 Suppl 2():6-8. PubMed ID: 1878723
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
